Becton Dickinson ($BDX) is buying California's Safety Syringes, a maker of anti-needlestick devices, looking to bolster its injectable offerings. BD didn't disclose ...

BD has turned to Mitsubishi Gas Chemical (MGC) to look into ways to improve the delivery of biologics, signing a letter of intent that positions it to assess its partner’s alternative to glass for ...

FRANKLIN LAKES, N.J., Nov. 30, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today issued the following statement regarding the U.S.

This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter. BD has increased its manufacturing capacity for critical ...

Becton, Dickinson and Company has the launched BD Emerald Syringe set of products that contain less material to address environmental impact, according to a news release by the company. The new ...

LE PONT-DE-CLAIX, France, Sept. 18, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced the commercial release of the BD Neopak™ ...

The Food and Drug Administration has posted a Class I notice about Becton Dickinson infusion pumps affected by compatibility issues with Cardinal Health Monoject syringes. Cardinal sent an urgent ...

Becton, Dickinson and Co. has announced it will acquire Safety Syringes, according to a news release. Safety Syringes, headquartered in Carlsbad, Calif., develops anti-needlestick devices for ...

FDA warns that compounded or repackaged drugs stored in certain syringes made by Becton-Dickinson may lose potency because of an interaction with the rubber stopper. FDA alerted healthcare ...

The FDA last week re-upped its recommendations that healthcare providers avoid using plastic syringes made in China wherever possible, while it continues to investigate growing quality concerns. In ...